Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases ...

ICMR and Panacea Biotec aim to finish enrollment for Phase 3 trials of India’s first indigenous dengue vaccine by October ...

Frost & Sullivan commends Novotech for setting a high standard in competitive strategy, execution, and market responsiveness.

In the July 2 release, 4DMT explained that the 25% layoffs are part of a move to “streamline operations to offset additional ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost ...

New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

Wondering about minoxidil 10% or higher for hair loss? When it comes to this topical product, a higher strength doesn’t ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

4D Molecular Therapeutics is cutting a quarter of its workforce to lower costs as it looks to become a commercial company. The late-stage biotechnology company said Wednesday that it is cutting ...